pharvaris.com - Nilai bisnis marang pendapatan PHVS

Simbol resmi perusahaan pharvaris.com (PHVS)

Robust funding of the European scientific headquarters of Pharvaris N.V. (PHVS) supports high liquidity, which is confirmed by current EV/Sales dynamics. The value 0.00 captures the current magnitude of the indicator. Growth prospects are based on the commercialization of oral treatments for HAE, while the final stages of clinical trials for bradykinin antagonists create potential for breakthrough market releases in the immunology sector.

PHVS Rasio nilai perusahaan marang pendapatan Pharvaris Pharma (23.11.2025 - 20.11.2026)

Pharvaris NV - rincian analitis lan metrik utama (PHVS)

Analisis wiwitan perusahaan:Pharvaris N.V. PHVS
Barang unggulan Pharvaris

For Pharvaris N.V. (PHVS), valuation through the lens of revenue allows for the measurement of the company's market potential while accounting for its debt. This metric aggregates market capitalization and net debt, dividing the result by sales volume. Analyzing the enterprise value-to-revenue ratio helps filter out market noise from actual business dynamics. This is critical as Lars Nibel prepares to launch a drug for the treatment of rare diseases. The current trend confirms the investment stability of the structure.

Analisis pesaing Pharvaris N.V.

ARGX - Multiplikator EV/Sales|BNTX: Multiplikator EV/Sales|ABVX (Abivax SA) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ADMA Corp|Multiplikator nilai perusahaan marang pendapatan Protagonist Therapeutics PTGX|Nilai perusahaan marang pendapatan IMVT (Immunovant Therapeutics)|Rasio total nilai perusahaan marang pendapatan kiniksa.com|Rasio nilai perusahaan marang pendapatan Grifols Biemat GRFS|Koefisien nilai perusahaan marang pendapatan ADPT (Adaptive Biotechnologies Corporation)|celldex.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Aurinia Pharma AUPH|biocryst.com (BCRX) - Rasio nilai perusahaan marang pendapatan|Vera Therapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Dianthus Therapeutics Inc|ABCL: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Tourmaline Bio, Inc. (TRML)|PGEN (Intrexon) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales PHAR (Pharming Corp)|nektar.com (NKTR) - Multiplikator nilai perusahaan marang pendapatan|UPB - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ZBIO (Zenas Biopharma)|IMNM: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Gossamer Bio, Inc. (GOSS)|Rasio nilai perusahaan marang pendapatan KalVista Pharmaceuticals|Septerna Inc (SEPN) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales PVLA|SVRA (Savara) - Nilai bisnis marang pendapatan|Rigel Pharma - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan AnaptysBio Corp (ANAB)|ATXS: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ENGN (enGene Holdings Inc.)|RAPT Therapeutics Inc. (RAPT) - Rasio nilai perusahaan marang pendapatan|Aerovate Therapeutics Inc (JBIO) - Multiplikator EV/Sales|ACRS (Aclaris Therapeutics, Inc) - Multiplikator EV/Sales|Kyverna (KYTX) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales TLSA|Nilai perusahaan marang pendapatan Cabaletta Bio, Inc. CABA|Ventyx Biosciences - Nilai perusahaan marang pendapatan|THTX: Rasio nilai perusahaan marang pendapatan|AVTX - Rasio nilai perusahaan marang pendapatan|ELDN: Rasio nilai perusahaan marang pendapatan|Agenus Inc. (AGEN) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Climb Bio Inc|ZURA (Zura Bio Ltd) - Multiplikator EV/Sales|Multiplikator EV/Sales aTyr Pharma Inc|Multiplikator EV/Sales ADAG|Rasio total nilai perusahaan marang pendapatan ImageneBio|Multiplikator EV/Sales STTK (Shattuck Labs Inc)|Multiplikator EV/Sales Equillium, Inc. EQ|CNTB - Rasio nilai perusahaan marang pendapatan|Immunic Therapeutics (IMUX) - Nilai perusahaan marang pendapatan|ATRA: Multiplikator EV/Sales|InflaRx GmbH (IFRX) - Multiplikator EV/Sales|XFOR (x4pharma.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Adicet Bio|Rasio nilai perusahaan marang pendapatan Celularity Inc (CELU)|Nilai perusahaan marang pendapatan INmune Bio Corp INMB|Rasio nilai perusahaan marang pendapatan Barinthus Biotherapeutics plc BRNS|KZR - Nilai perusahaan marang pendapatan|sabbiotherapeutics.com - Multiplikator EV/Sales|akaritx.com (AKTX) - Nilai perusahaan marang pendapatan|ENLV: Multiplikator EV/Sales|QTTB (Q32 Bio Inc) - Rasio nilai perusahaan marang pendapatan|GOVX (geovax.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Edesa Biotech Corp|Multiplikator EV/Sales IBIO|Nilai perusahaan marang pendapatan Carisma Tx CARM|Rasio nilai perusahaan marang pendapatan XTL Biopharmaceuticals Ltd XTLB|Multiplikator EV/Sales Bolt Biotherapeutics BOLT|HCW Biologics - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan aptevotherapeutics.com|AIM (AIM ImmunoTech, Inc.) - Nilai perusahaan marang pendapatan|Aditxt Corp - Nilai bisnis marang pendapatan|GRI (GRI Bio Inc) - Multiplikator EV/Sales|Multiplikator EV/Sales XORTX Therapeutics Inc|Rasio nilai perusahaan marang pendapatan Vyome Therapeutics (HIND)|REVB - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Indaptus Therapeutics, Inc. INDP|Multiplikator EV/Sales scinai.com SCNI|CalciMedica Inc - Multiplikator EV/Sales|AFMD - Multiplikator EV/Sales|ALLK: Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - Multiplikator EV/Sales|ITOS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan OCEA (Ocean Biomedical)|TCBP: Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Third Harmonic Bio Inc THRD